Skip to main content
OpenTrials
Completed

NCT Number: NCT02532959

Diagnostic Breath Analysis Study to Detect Sepsis

Analysis of exhaled breath samples using a high-speed gas chromatography medical device will identify Volatile Organic Compounds (VOC) that are specifically associated with SIRS and Sepsis.

Primary outcome measures will include the assessment of the zNose Diagnostic Breath Analysis System, which includes high-speed gas chromatography, in the early detection of SIRS and Sepsis as compared with current SIRS and Sepsis evaluation methods.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ventura County Medical Center

Ventura, California, 93003, United States

About this study

Exhaled breath samples were collected in a Tedlar bag or with a proprietary collection tube. The collection devices are clean and intended for single-use. They are manufactured with approved medical grade materials. Patients were asked to breath into a single-use, medical grade mouthpiece which is connected to the collection bag or tube. The design of the collection devices does not allow the patient to rebreathe the exhaled gas sample. Patients enrolled in the clinical study were asked to breathe into the breath collection device for 2 to 4 breaths. Breath collection is completely non-invasive. Breath samples were held for 30 days and retested at the end of the 30 day period to determine if the VOC profile has changed over time.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Inclusion criteria

  • Age 18 years of age or older
  • Able to give written and dated informed consent prior to any study specific procedures.
  • Able to follow instructions for specific breathing maneuvers.
  • Able to breath into a medical grade tube, vial or bag.
  • Initial assessment and screening indicates SIRS or Sepsis.

Exclusion criteria

Exclusion criteria

  • Cognitively impaired and unable to complete informed consent documents.
  • Unable to follow instructions during testing.
  • Severe dyspnea.
  • Use of supplement oxygen which cannot be discontinued during testing.
  • Unable to perform breathing maneuvers required to provide multiple breath samples.
  • Swallowing disorders or chronic aspiration.
  • History of pneumothorax.
  • Patients requiring mechanical ventilation
  • Patients who are pregnant.
  • Patients who have smoked cigarettes or cigars within 30 days prior to trial admission.

Treatment and study plan

Diagnostic Breath Analysis

Device

Conduct exhaled breath samples

Primary outcomes

  1. Diagnostic Breath Analysis

    Time frame: 6 months

    Diagnostic Breath Analysis to identify Volatile Organic Compounds (VOC) associated with Sepsis and SIRS

Sponsors and collaborators

Lead sponsor

Landon Pediatric Foundation

Other

Registry information

Official study title

Pilot Study to Evaluate Diagnostic Breath Analysis for Early Detection of Systemic Inflammatory Response Syndrome (SIRS) and Sepsis

Important dates

Study start
2015
Primary completion
2015
Study completion
2015
First posted
Aug 26, 2015
Registry last updated
Sep 8, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.